DK1768691T3 - Aequorinholdige præparater og fremgangsmåder til anvendelse af samme - Google Patents
Aequorinholdige præparater og fremgangsmåder til anvendelse af sammeInfo
- Publication number
- DK1768691T3 DK1768691T3 DK05766584.6T DK05766584T DK1768691T3 DK 1768691 T3 DK1768691 T3 DK 1768691T3 DK 05766584 T DK05766584 T DK 05766584T DK 1768691 T3 DK1768691 T3 DK 1768691T3
- Authority
- DK
- Denmark
- Prior art keywords
- aequorin
- methods
- same
- containing preparations
- preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/872,795 US20060229243A1 (en) | 2004-06-21 | 2004-06-21 | Aequorin-containing compositions and methods of using same |
PCT/US2005/021770 WO2006010004A2 (en) | 2004-06-21 | 2005-06-21 | Aequorin-containing compositions and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1768691T3 true DK1768691T3 (da) | 2013-07-01 |
Family
ID=35785748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05766584.6T DK1768691T3 (da) | 2004-06-21 | 2005-06-21 | Aequorinholdige præparater og fremgangsmåder til anvendelse af samme |
Country Status (21)
Country | Link |
---|---|
US (3) | US20060229243A1 (da) |
EP (2) | EP1768691B1 (da) |
JP (1) | JP4971150B2 (da) |
KR (1) | KR101213555B1 (da) |
CN (1) | CN1997383B (da) |
AU (1) | AU2005265266B2 (da) |
BR (1) | BRPI0512392B1 (da) |
CA (1) | CA2571542C (da) |
CY (1) | CY1114307T1 (da) |
DK (1) | DK1768691T3 (da) |
ES (1) | ES2422173T3 (da) |
HK (1) | HK1109576A1 (da) |
IL (1) | IL180195A (da) |
MX (1) | MXPA06015037A (da) |
NZ (1) | NZ552274A (da) |
PL (1) | PL1768691T3 (da) |
PT (1) | PT1768691E (da) |
SG (1) | SG153848A1 (da) |
SI (1) | SI1768691T1 (da) |
WO (1) | WO2006010004A2 (da) |
ZA (1) | ZA200610688B (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
GB0625678D0 (en) | 2006-12-21 | 2007-01-31 | Lux Biotechnology Ltd | Composition and method for detection of demineralisation |
MX2010009753A (es) * | 2008-03-11 | 2010-09-30 | Quincy Bioscience Llc | Composiciones que contienen apoaecuorina y metodos de uso de las mismas. |
JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
JP5886762B2 (ja) * | 2010-12-24 | 2016-03-16 | 大塚製薬株式会社 | 生理活性物質を検出するバイオアッセイ法 |
DK2780027T3 (da) * | 2011-11-15 | 2017-09-25 | Quincy Bioscience Llc | Apoaequorin til begrænsning af iskæmiforvoldte nerveskader. |
GB201700317D0 (en) | 2017-01-09 | 2017-02-22 | Calcivis Ltd | Detection device |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240855A (ja) * | 2000-03-01 | 2001-09-04 | Masashi Sugimoto | 生物発光方法及び発光物品 |
US6800492B2 (en) * | 2000-06-01 | 2004-10-05 | Institute Pasteur | Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
AU2001268328A1 (en) * | 2000-06-12 | 2001-12-24 | University Of Maryland Biotechnology Institute | Method of controlling the binding of calmyrin to presenilin |
US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
-
2004
- 2004-06-21 US US10/872,795 patent/US20060229243A1/en not_active Abandoned
-
2005
- 2005-06-21 WO PCT/US2005/021770 patent/WO2006010004A2/en active Application Filing
- 2005-06-21 PT PT57665846T patent/PT1768691E/pt unknown
- 2005-06-21 CN CN200580024585XA patent/CN1997383B/zh active Active
- 2005-06-21 MX MXPA06015037A patent/MXPA06015037A/es active IP Right Grant
- 2005-06-21 PL PL05766584T patent/PL1768691T3/pl unknown
- 2005-06-21 KR KR1020077001461A patent/KR101213555B1/ko active IP Right Grant
- 2005-06-21 NZ NZ552274A patent/NZ552274A/en unknown
- 2005-06-21 AU AU2005265266A patent/AU2005265266B2/en active Active
- 2005-06-21 BR BRPI0512392-5A patent/BRPI0512392B1/pt active IP Right Grant
- 2005-06-21 ES ES05766584T patent/ES2422173T3/es active Active
- 2005-06-21 SG SG200904273-0A patent/SG153848A1/en unknown
- 2005-06-21 EP EP05766584.6A patent/EP1768691B1/en active Active
- 2005-06-21 DK DK05766584.6T patent/DK1768691T3/da active
- 2005-06-21 SI SI200531724T patent/SI1768691T1/sl unknown
- 2005-06-21 CA CA2571542A patent/CA2571542C/en active Active
- 2005-06-21 JP JP2007518179A patent/JP4971150B2/ja active Active
- 2005-06-21 EP EP12188025.6A patent/EP2545934B1/en not_active Not-in-force
- 2005-06-21 US US11/571,043 patent/US7671015B2/en active Active
-
2006
- 2006-12-19 IL IL180195A patent/IL180195A/en active IP Right Grant
- 2006-12-19 ZA ZA200610688A patent/ZA200610688B/en unknown
-
2008
- 2008-01-10 HK HK08100338.3A patent/HK1109576A1/xx unknown
-
2010
- 2010-01-27 US US12/694,427 patent/US20100152117A1/en not_active Abandoned
-
2013
- 2013-06-14 CY CY20131100486T patent/CY1114307T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
NO20032220D0 (no) | Löfteverktöy II og fremgangsmåte for anvendelse av samme | |
DK1877090T3 (da) | Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf | |
DK1948852T3 (da) | Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden | |
IS8204A (is) | Tæki og aðferð til að hluta niður | |
DK1765327T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
DK1575416T3 (da) | Fremgangsmåder til diagnosticering af præeklampsi | |
DK1732548T4 (da) | Fremgangsmåder til anvendelse af aminopyridin-depotpræparater | |
DK1701968T3 (da) | Immunogene peptid-bærer-konjugater og fremgangsmåder til deres fremstilling | |
DK2929891T3 (da) | Fremgangsmåde til modulering af appetitten | |
DK1718155T3 (da) | Fremgangsmåder til anvendelse af probiotiske bifidobakterier til selskabsdyr | |
DK1725253T3 (da) | Medikamenter og fremgangsmåder til behandling af hovedpine | |
IS7726A (is) | Pyrazólólpyridín og aðferðir til þess að búa þau til og nota | |
DK1965763T3 (da) | Stabile enzympræparater og fremgangsmåder til anvendelse heraf | |
NO20054709L (no) | Sammenfoyningssystem og anvendelse av dette | |
DK1817055T3 (da) | Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf | |
DK1954713T3 (da) | Modificerede grønfluorescerende proteiner og fremgangsmåder til anvendelse af samme | |
DK1511734T3 (da) | Forbindelser, præparater og fremgangsmåder | |
DK1864987T3 (da) | Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater | |
DK1840121T3 (da) | Glycinderivat og anvendelse heraf | |
DK1768691T3 (da) | Aequorinholdige præparater og fremgangsmåder til anvendelse af samme | |
DE502004002225D1 (de) | Selbstemulgierende Zubereitungen | |
DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
IS7572A (is) | Aðferð og efni til lækninga | |
DK1743101T3 (da) | Centrifugalpumpe og fremgangsm de til fremstilling af samme |